Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

11.60
-0.4500-3.73%
Pre-market: 11.700.1000+0.86%08:30 EDT
Volume:350.14K
Turnover:4.12M
Market Cap:30.37M
PE:- -
High:12.16
Open:12.01
Low:11.46
Close:12.05
52wk High:36.00
52wk Low:9.23
Shares:2.62M
Float Shares:2.62M
Volume Ratio:1.36
T/O Rate:13.37%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

After Ozempic, Novo Nordisk Bets On Anthropic—While Pharma Still Awaits AI's First Approved Drug

Bellwether Stocks Movement
·
11 hours ago

Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig

TIPRANKS
·
1 hour ago

Novo, Orbis Sign up to $1.4 Billion Deal to Develop Oral Drugs

Reuters
·
1 hour ago

Sector Update: Healthcare

MT Newswires Live
·
17 hours ago

Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal is Betting on It.

Dow Jones
·
19 hours ago

Novo Nordisk Will Use Anthropic's Claude for Drug Research

Dow Jones
·
20 hours ago

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
20 hours ago

Novo Nordisk announces collaboration with Anthropic

TIPRANKS
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
Sep 15

Sector Update: Healthcare

MT Newswires Live
·
Sep 15

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
Sep 15

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Sep 15

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Sep 15

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14